Snowflake Inc. SNOW said Tuesday it priced an upsized $3.75 billion private offering of 0% convertible senior notes. The offering includes $2 billion of notes due in 2029 and $1.75 billion due in 2031 ...
Snowflake Inc (NYSE:SNOW) plans to offer $3.5 billion of convertible senior notes alongside planned transactions to reduce potential dilution. The company said Monday its planned private placement to ...
InvestorsHub on MSN
Snowflake shares fall after $3.5 billion convertible note offering
Snowflake (NYSE:SNOW) shares fell 4% on Monday after the enterprise software company announced plans to raise $3.5 billion ...
Snowflake's massive convertible note proposal is rattling cloud stocks across the board, but the deal's unusual structure ...
Axon Enterprise has completed a US$1.00 billion offering of zero-coupon, unsecured convertible senior notes due September 15, 2031, alongside expanding its revolving credit facility through a second ...
The company plans to use the proceeds to increase its Bitcoin reserves, manage debt, and limit shareholder dilution through capped call strategies. Today, MARA Holdings, Inc. (NASDAQ: MARA) announced ...
TransCode Therapeutics paid Yorkville $840,975 on October 1, 2026, which included $759,000 in outstanding principal, a ...
Bilibili prices $700M in zero-coupon convertible notes due 2031, with Tencent subscribing $200M and a concurrent $300M share buyback program.
OPKO Health Announces Convertible Notes Redeemable Until End of 2026 Following Stock Price Milestone
On October 2, 2026, OPKO Health, Inc. filed an 8-K revealing that its 3.75% Convertible Senior Notes due 2029 have become ...
Beyond Meat (BYND) announced that approximately 97% of its $1.15 billion in convertible notes due March 2027 were tendered by the early tender deadline for its exchange offer. This should buy Beyond ...
Convertible instruments held steady in Q1 2025, but the terms are shifting in favor of investors. Interest rates on convertible notes rose by 200 to 300 basis points, and discount rates climbed as ...
The Notes have an initial conversion price of approximately $139.84 per share, representing a 27.5% premium to Halozyme's September 17 closing price of $109.68. Conversions will be settled in cash and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results